Posted inBiotechnology
VaxLab: Fast, Integrated mRNA Vaccine Design Platform
In the dynamic world of vaccine development, a groundbreaking innovation promises to transform how quickly and effectively mRNA vaccines can…
Posted inBiotechnology
L-RNA Aptamer Enhances Glioblastoma Therapy in GLORIA Trial
In an unprecedented advancement in glioblastoma treatment, a groundbreaking phase I/II clinical trial known as GLORIA has unveiled promising results…
Posted inBiotechnology
Natural Compound PGG Triggers Pyroptosis to Enhance Anti-Tumor Immune Response
In a groundbreaking advancement poised to reshape cancer immunotherapy, researchers at Shanghai Medical College, Fudan University, have unveiled a novel…
Posted inGenetics
Plant Molecular Farming Comes of Age
Plant molecular farming (PMF) may seem like a bold option for companies accustomed to mammalian or microbial systems, but recent…
Posted inGenetics
Redefining Bioprocessing Using Reservoirs of Biochemical Diversity
In the global race to improve how medicines are made, scientists are turning to an unlikely source of innovation: the…
Posted inGenetics
Faster Process Development via “Transfer Learning”
An emerging artificial intelligence technique called “transfer learning” could help drug makers use data to speed up the development of…
Posted inGenetics
Forecasting Protein Aggregation with an Improved Algorithm
A new, improved algorithm for studying protein aggregation could help biologics manufacturers design better-performing products with less experimental effort. The software,…
Posted inBiotechnology
Community Study Uncovers PAH Exposure in West Eugene
In a groundbreaking study released in April 2026, researchers have embarked on one of the most comprehensive community-engaged assessments of…
Posted inBiotechnology
Beyond the Hype: Turning NAMs into Actionable Evidence
There's a shift happening in how safety and efficacy are evaluated across drug development, chemicals, and beyond, and it's well past the theoretical stage. New…
Posted inBiotechnology
Insilico Medicine Names ISM6200 as a Promising Best-in-Class Selective NR3C1 Inhibitor for Ovarian Cancer, Cushing’s Syndrome, Obesity Linked to Hypercortisolism, and Glaucoma
In a groundbreaking stride forward in the realm of therapeutic innovation, Insilico Medicine, a clinical-stage company harnessing the power of…